FAQ

response to cyclophosphamide

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1967-2018
02419672018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Dual-modality monitoring of tumor response to cyclophosphamide therapy in mice with bioluminescence imaging and small-animal positron emission tomography.
The purpose of this study was to noninvasively monitor the therapeutic efficacy of cyclophosphamide (CTX) in a mouse model by… (More)
Is this relevant?
2008
2008
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease.
RATIONALE The presence of inflammatory cells on bronchoalveolar lavage is often used to predict disease activity and the need for… (More)
Is this relevant?
2007
2007
Gene signature-based prediction of tumor response to cyclophosphamide.
Cyclophosphamide (CY) is a clinically used cytotoxic agent that is effective in a wide range of tumor types including breast and… (More)
  • figure 1
  • table I
  • figure 2
  • table II
  • figure 3
Is this relevant?
2006
2006
Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer.
PURPOSE Only about 50% of metastatic breast cancer patients benefit from cytotoxic chemotherapy. Today, no validated markers… (More)
  • table 1
  • figure 1
Is this relevant?
2004
2004
Fas signaling is involved in the control of hair follicle response to chemotherapy.
Chemotherapeutic agents induce p53-dependent apoptosis in the hair follicle (HF) resulting in hair loss, a common side effect of… (More)
Is this relevant?
2001
2001
Quantitative T1rho magnetic resonance imaging of RIF-1 tumors in vivo: detection of early response to cyclophosphamide therapy.
This study compares two potential magnetic resonance imaging (MRI) indices for noninvasive early detection of tumor response to… (More)
Is this relevant?
2001
2001
Cyclophosphamide stimulates lung fibroblasts to release neutrophil and monocyte chemoattractants.
Cyclophosphamide is an alkylating antineoplastic agent used in several conditions. However, little is known about the mechanism… (More)
Is this relevant?
2000
2000
Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome
Development of steroid dependency represents a significant therapeutic challenge in steroid-sensitive nephrotic syndrome… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
1984
1984
Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
The response to and clinical outcome of cyclophosphamide therapy were retrospectively assessed in 29 steroid-resistant patients… (More)
Is this relevant?
1981
1981
Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
The effect has been studied of adding either misonidazole (MISO) or the radioprotective drug, WR 2721, to cyclophosphamide (CY… (More)
  • figure 1
  • table I
  • figure 2
  • table III
  • table IV
Is this relevant?